Picture of Spirax logo

SPX Spirax News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsBalancedLarge CapHigh Flyer

REG - Spirax Group PLC - External Directorships held by Company Directors

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260514:nRSN4030Ea&default-theme=true

RNS Number : 4030E  Spirax Group PLC  14 May 2026

 

14 May 2026

 

Spirax Group plc (the "Company")

Update on External Directorships held by Company Directors

 

Pursuant to Listing Rule 6.4.9R, requirement to give notice of a change in
directorships held by directors in another publicly quoted company, the
Company announces that Tim Cobbold, Chair of the Company, will join the board
of Coats Group plc ('Coats'), a world-leading Tier 2 supplier of critical
components to the apparel and footwear industries on 1 July 2026, as
non-executive director and chair designate.

 

Tim will become chair of the board of Coats Group plc on 1 August 2026. This
appointment is in addition to his existing role as chair of the Board of
Spirax Group plc.

 

 

Enquiries:

Spirax
Group:
+44 (0) 1242 535 000

Mal Patel, Head of Investor Relations
investors@spiraxgroup.com (mailto:investors@spiraxgroup.com)

Hazel Meldrum, Group Head of Communications
communications@spiraxgroup.com (mailto:communications@spiraxgroup.com)

Celine Barroche, Company Secretary                           +44
(0) 1242 535 276

 

About Spirax Group plc

Spirax Group is positioned to play a critical role in enabling the industrial
transition to net zero, aligned to our Purpose to create sustainable value for
all our stakeholders as we engineer a more efficient, safer and sustainable
world.  We put solving customers' problems at the heart of our total
solutions approach.  Our global thermal energy and fluid technology
solutions improve operating efficiency and safety in our customers' critical
industrial processes.  Our new-to-world decarbonisation* solutions will use
our proprietary technologies to electrify boilers, for the raising of steam,
as well as the electrification of other critical industrial process heating
applications.

Spirax Group comprises three strong and aligned Businesses: Steam Thermal
Solutions helps customers control and manage steam within their mission
critical industrial applications, such as
cleaning, sterilising, cooking and heating.  We are helping to put food
safely on the world's tables and keeping our hospitals running. Electric
Thermal Solutions has proprietary technologies that deliver electrification
solutions at scale in industrial settings, including for the raising of steam,
supporting our customers to achieve their net zero goals. We also deliver
freeze protection and defrost solutions critical to aviation and space
industries and ensure thermal uniformity in Semiconductor chip manufacturing
to power the critical electronic systems we rely on.  Watson‐Marlow Fluid
Technology Solutions is engineering vital fluid technology solutions
that optimise the efficient use of resources and support advancements in
global health, such as lifesaving vaccines and gene therapies.

Spirax Group is headquartered in Cheltenham (UK). We have over
30 strategically located manufacturing plants around the world and are
committed to creating a safe and inclusive working culture for our 10,000
colleagues, operating in nearly 70 countries and serving over 100,000
customers globally.

The Company's shares have been listed on the London Stock Exchange since 1959
(symbol: SPX) and we are a constituent of the FTSE 100 and the FTSE4Good
Indexes.

 

* Eliminates scopes 1 and 2 greenhouse gas emissions when connected to a
green electricity source.

 

Further information can be found at spiraxgroup.com
(http://www.spiraxsarcoengineering.com/)

 

LEI 213800WFVZQMHOZP2W17

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNFLFSVEVISLIR



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Spirax

See all news